ATE312599T1 - Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten - Google Patents
Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthaltenInfo
- Publication number
- ATE312599T1 ATE312599T1 AT00964471T AT00964471T ATE312599T1 AT E312599 T1 ATE312599 T1 AT E312599T1 AT 00964471 T AT00964471 T AT 00964471T AT 00964471 T AT00964471 T AT 00964471T AT E312599 T1 ATE312599 T1 AT E312599T1
- Authority
- AT
- Austria
- Prior art keywords
- liposomes
- vaccines
- nucleic acid
- oral use
- contain liposomes
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 5
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 229940126578 oral vaccine Drugs 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 150000001767 cationic compounds Chemical class 0.000 abstract 1
- 125000001165 hydrophobic group Chemical group 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 238000009877 rendering Methods 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99307786 | 1999-10-01 | ||
| PCT/GB2000/003773 WO2001024773A1 (en) | 1999-10-01 | 2000-10-02 | Liposome-entrapped dna oral vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312599T1 true ATE312599T1 (de) | 2005-12-15 |
Family
ID=8241653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00964471T ATE312599T1 (de) | 1999-10-01 | 2000-10-02 | Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7008791B1 (https=) |
| EP (1) | EP1217989B1 (https=) |
| JP (1) | JP2003529550A (https=) |
| KR (1) | KR100744237B1 (https=) |
| CN (1) | CN1196474C (https=) |
| AT (1) | ATE312599T1 (https=) |
| AU (1) | AU7540500A (https=) |
| CA (1) | CA2386024A1 (https=) |
| DE (1) | DE60024843T2 (https=) |
| ES (1) | ES2256043T3 (https=) |
| WO (1) | WO2001024773A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7604803B2 (en) * | 2002-07-05 | 2009-10-20 | Lipoxen Technologies Limited | Method to enhance an immune response of nucleic acid vaccination |
| AU2004238076A1 (en) * | 2003-05-09 | 2004-11-25 | Novosom Ag | Injectable liposomal depots for delivering active ingredients |
| JP4255396B2 (ja) * | 2004-03-19 | 2009-04-15 | 津田駒工業株式会社 | 水噴射式織機の水受け装置 |
| CA2687208C (en) * | 2006-12-22 | 2017-02-14 | Soluciones Biotecnologicas Innovacion Ltda | Process and formulation for immunizing fish in aquaculture systems |
| EP2146692A1 (en) * | 2007-03-19 | 2010-01-27 | Fresenius Kabi Oncology Limited | Proliposomal and liposomal compositions |
| CN101940320B (zh) * | 2010-08-06 | 2012-08-29 | 南昌大学 | 薄膜分散-动态高压微射流制备中链脂肪酸纳米脂质体 |
| CN101940321B (zh) * | 2010-08-06 | 2012-06-20 | 南昌大学 | 动态高压微射流-冻融法制备中链脂肪酸纳米脂质体 |
| EP2708134A1 (en) | 2012-09-17 | 2014-03-19 | Unilever N.V. | Dough compositions comprising a structured fat phase |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1138533C (zh) * | 1996-09-13 | 2004-02-18 | 利普森有限公司 | 脂质体 |
| FR2760193B1 (fr) * | 1997-02-28 | 1999-05-28 | Transgene Sa | Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules |
-
2000
- 2000-10-02 WO PCT/GB2000/003773 patent/WO2001024773A1/en not_active Ceased
- 2000-10-02 CN CNB008134766A patent/CN1196474C/zh not_active Expired - Fee Related
- 2000-10-02 AT AT00964471T patent/ATE312599T1/de not_active IP Right Cessation
- 2000-10-02 CA CA002386024A patent/CA2386024A1/en not_active Abandoned
- 2000-10-02 US US10/089,312 patent/US7008791B1/en not_active Expired - Fee Related
- 2000-10-02 AU AU75405/00A patent/AU7540500A/en not_active Abandoned
- 2000-10-02 KR KR1020027003922A patent/KR100744237B1/ko not_active Expired - Fee Related
- 2000-10-02 EP EP00964471A patent/EP1217989B1/en not_active Expired - Lifetime
- 2000-10-02 ES ES00964471T patent/ES2256043T3/es not_active Expired - Lifetime
- 2000-10-02 DE DE60024843T patent/DE60024843T2/de not_active Expired - Lifetime
- 2000-10-02 JP JP2001527772A patent/JP2003529550A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US7008791B1 (en) | 2006-03-07 |
| EP1217989B1 (en) | 2005-12-14 |
| CA2386024A1 (en) | 2001-04-12 |
| EP1217989A1 (en) | 2002-07-03 |
| JP2003529550A (ja) | 2003-10-07 |
| AU7540500A (en) | 2001-05-10 |
| WO2001024773B1 (en) | 2001-08-16 |
| KR20030011763A (ko) | 2003-02-11 |
| KR100744237B1 (ko) | 2007-07-30 |
| CN1376056A (zh) | 2002-10-23 |
| CN1196474C (zh) | 2005-04-13 |
| DE60024843T2 (de) | 2006-08-10 |
| WO2001024773A1 (en) | 2001-04-12 |
| ES2256043T3 (es) | 2006-07-16 |
| DE60024843D1 (de) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5651959A (en) | Ultramulsion based oral care compositions | |
| WO2003030934A3 (en) | Cpg formulations and related methods | |
| WO2002041765A3 (en) | Biodegradable bioadhesive controlled release system of nano-particles for oral care products | |
| TW200507874A (en) | Immunostimulatory nucleic acid oil-in-water formulations and related methods of use | |
| ATE355826T1 (de) | Verfahren zur verkapselung von nukleinsäuren in lipiddoppelschichten | |
| JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
| ATE234919T1 (de) | Antisense nukleinsäuren zur vorbeugung und behandlung von beschwerden in welchen die exprimierung von c-erbb-2 eine rolle spielt | |
| ATE326205T1 (de) | Tensidfreietopische zusammensetzungen und verfahren zur schnelle herstellung davon | |
| AU2001295671A1 (en) | Pharmaceutical composition for immunisation against aids | |
| AU3113893A (en) | Flavour-masked pharmaceutical compositions | |
| ATE312599T1 (de) | Impfstoffe zur oralen verwendung die liposomen sowie eine nukleinsäure enthalten | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| Singh et al. | Novasome-a breakthrough in pharmaceutical technology a review article | |
| ATE285239T1 (de) | Dna enthaltende impfstoffen | |
| Kinane | Aetiology and pathogenesis of periodontal disease | |
| DE60310605D1 (de) | Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung | |
| US5733529A (en) | Ultramulsion based antigingivitis toothpaste compositions | |
| BR0206112A (pt) | Vacinas de ácido nucléico usando ácidos nucléicos de codificação de antìgeno de tumor com ácido nucleìco de codificação de auxiliar de citocina | |
| WO2003050067A3 (fr) | Analogues de la vitamine d | |
| BR9807927A (pt) | Uso de uma leishmania mutante na preparação de uma vacina, formulação de vacina, processo de vacinação contra leishmania, uso de uma leishmania mutante na preparacão de uma vacina para a profilaxia e/ou o tratamento de leishmaniose, e, formulação farmacêutica | |
| WO2001082892A3 (de) | Wirkstoffhaltige liposome | |
| DE60124862T2 (de) | Verbesserte dns-impfstoffe für rinder-herpes-virus 1 | |
| ATE121298T1 (de) | Verfahren zur herstellung eines antikaries- impfstoffes aus streptococcus mutans und impfzusammensetzung gegen karies in form von nasentropfen. | |
| DZ3103A1 (fr) | Nouvelles pyrazolo Ä4,3-EÜdiazépines substituées, compositions pharmaceutiques les contenant, utili sation à titre de médicament et procédés pour leurs préparation. | |
| WO2002036160A3 (es) | Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |